NEW YORK (GenomeWeb) – Qiagen took another step towards completing its DKK683 million ($105 million) acquisition of RNA analysis products developer Exiqon by reducing the acceptance threshold of the share capital and voting rights in Exiqon to around 89 percent from 90 percent.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.